The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus - ScienceDirect
Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis | Scientific Reports
Vancomycin-Intermediate/Resistant Staphylococcus aureus Laboratory Testing Algorithm | HAI | CDC
Toxins | Free Full-Text | In Vitro and In Vivo Antibacterial Activity of Gliotoxin Alone and in Combination with Antibiotics against Staphylococcus aureus
Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea | Scientific Reports
Vancomycin-intermediate resistance in Staphylococcus aureus - ScienceDirect
Figure 1 from Chapter 3 Glycopeptide Resistance in S . aureus | Semantic Scholar
Cureus | Reduced Susceptibility and Resistance to Vancomycin of Staphylococcus aureus: A Review of Global Incidence Patterns and Related Genetic Mechanisms
Intermediate-Type Vancomycin Resistance (VISA) in Genetically-Distinct Staphylococcus aureus Isolates Is Linked to Specific, Reversible Metabolic Alterations | PLOS ONE
Journals and Conferences on Infectious Diseases - Vancomycin Resistant Staphylococcus aureus from Clinical Isolates in Zaria Metropolis, Kaduna State ============================= Vancomycin antibiotic is a well-known #drug of last resort in the treatment
Staphylococcus aureus and Staphylococcus epidermidis